Science & Tech
News: Science & Tech
All News Stories
UofL-born cell therapy for organ transplants enters Phase 3 trial
August 27, 2020
A cell therapy born at the University of Louisville that could improve the lives of kidney transplant recipients has entered its Phase 3 clinical trial — the last step before applying for FDA approval.
UofL immunologist summarizes functions of protein family associated with obesity
August 20, 2020
Fatty acid binding proteins (FABPs) serve as a type of chaperone, coordinating the transport of fatty acids and other molecules between cells.
UofL, partners select promising health-tech projects for funding
August 13, 2020
The Kentucky Network for Innovation & Commercialization (KYNETIC) has selected its first round of promising university-born health and medical technologies, each of which will receive training and $50,000 for development.